Wilmington Trust National Association’s Regeneron Pharmaceuticals REGN Stock Holding History

Wilmington Trust National Association’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$3.71M	Buy	13,120 +12,300	+1,500%	+$3.65M	0.13%	144
2014 Q1	$246K	Buy	+820	New	+$253K	0.01%	525
2013 Q4	–	Sell	-1,016	Closed	-$318K	–	581
2013 Q3	$318K	Sell	1,016 -1,511	-60%	-$397K	0.01%	440
2013 Q2	$568K	Buy	+2,527	New	+$588K	0.02%	308

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Trust National Association's REGN Position: Q2 2014 in Review

Wilmington Trust National Association increased its Regeneron Pharmaceuticals (REGN) stake by 1,500% in Q2 2014, buying an estimated $3.65M and bringing the position to 13,120 shares worth $3.71M. The position accounts for 0.13% of the portfolio, ranked #144.

Wilmington Trust National Association first reported a position in REGN in Q2 2013 and has held it in 4 quarters since. 447 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

Wilmington Trust National Association held 13,120 shares of Regeneron Pharmaceuticals worth $3.71M as of Q2 2014.
Wilmington Trust National Association bought 12,300 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $3.65M.
Regeneron Pharmaceuticals made up 0.13% of Wilmington Trust National Association's portfolio in Q2 2014, its #144 holding.
Wilmington Trust National Association first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
447 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.